Cerule International is a pioneering biotech company with a mission to "Building Extraordinary Lives®" with its range of cutting-edge dietary supplements and skin care products. The company has been impacting lives worldwide for over a decade by providing scientifically validated products supported by years of research and patents. Cerule's flagship product, StemEnhance® Ultra, has revolutionized the natural healthcare industry as the world's first clinically proven and patented stem cell enhancer, enhancing the lives of numerous individuals globally. In addition to StemEnhance® Ultra, Cerule has developed other proprietary products such as Cyactiv®, Cyactiv® Joint, PlasmaFlo®, Cerule Skin Instant Tensor Serum, CC Cream, and Micellar Gel, reinforcing its position as an industry leader in the health and wellness sector. As a global relationship marketing company, Cerule has been founded on the pursuit of innovative, science-based products that enhance and prolong the quality of life. Cerule International consistently challenges the status quo, advocating for the possible extraordinary and aiming to develop groundbreaking health solutions. The company's commitment to truth, hard work, and customer care underscores its collective success. With a founding date in 1999, it operates in the industries of Biotechnology, Health Care, and Health and Wellness. For more information, visit www.cerule.com.
There is no investment information
No recent news or press coverage available for Cerule International .